Acute coronary syndrome - A frequent clinical manifestation of bare metal in-stent restenosis

Kardiologia Polska

Volumn 68, Issue 6, 2010, Pages 637-645

  Drozd, Jakub ^a   Wójcik, Jarosław ^a   Małek, Robert ^b   Korona, Beata ^b   Zapolski, Tomasz ^a   Wysokiński, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b SPSK4 ^*  (Poland)

Author keywords

Acute coronary syndrome; Bare metal stent; In stent restenosis

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BARE METAL STENT; CARDIOVASCULAR RISK; CAUCASIAN; CINEANGIOCARDIOGRAPHY; CLINICAL PRACTICE; COMPARATIVE STUDY; CORRELATION ANALYSIS; DATA BASE; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RECURRENT DISEASE; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

EID: 77953751817     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bossi I, Klersy C, Black A et al. In-stent restenosis: long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty. J Am Coll Cardiol, 2000; 35: 1569-1976. (Pubitemid 30307502)
2. Kastrati A, Schoming A, Elezi S et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol, 1997; 30: 1428-1436. (Pubitemid 27486458)
3. Bauters C, Hubert E, Prat A et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol, 1998; 31: 1291-1298. (Pubitemid 28219119)
4. Mintz GS, Hoffmann R, Mehran R et al. In-stent restenosis: the Washington Hospital Center experience. Am J Cardiol, 1998; 81: 7E-13E. (Pubitemid 28182622)
5. Mehran R, Dangas G, Abizaid AS et al. Angiographic patterns of in-stent restenosis: classification for long-term out-come. Circulation, 1999; 100: 1872-1878. (Pubitemid 29511140)
6. Fischman DL, Leon MB, Baim DS et al.; for the Stent Restenosis Study Investigators. A randomised comparison of coronary artery disease. N Engl J Med, 1994; 331: 496-501.
7. Serruys PW, de Jaegere P, Kiemenij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. BENESTENT Study Group. N Engl J Med, 1994; 331: 489-495.
8. Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug eluting stents. JAMA, 2005; 293: 2126-2130.
9. Lagerqvist B, James SK, Stenestrand U et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med, 2007; 356: 1009-1019. (Pubitemid 46376801)
10. Kastrati A, Mehilli J, Pache J et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med, 2007; 356: 1030-1039.
11. Daemen J, Ong AT, Stefanini GG et al. Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Am J Cardiol, 2006; 98: 895-901. (Pubitemid 44402258)
12. Mehran R, Dangas R, Abizaid AS et al. Angiographic Patterns of In-Stent Restenosis: classification and implications for long-term outcome. Circulation, 1999; 100: 1872-1878. (Pubitemid 29511140)
13. Levine GN, Chodos AP, Loscalzo J. Restenosis following coronary angioplasty: clinical presentation and therapeutic options. Clin Cardiol, 1995; 18: 693-703. (Pubitemid 26034662)
14. Holmes DR, Vlietstra RE, Smith HC et al. Restenosis after percutaneous transluminal angioplasty: a report from the PTCA registry of the National Heart, Lung, and Blood Institute. Am J Cardiol, 1984; 53: 77C-81C.
15. Nelson CL, Tcheng JE, Frid DJ et al. Incomplete angiographic follow-up of results in significant underestimation of true restenosis rates after PTCA. Circulation, 1990; 1237 (suppl. III): III312.
16. Kearney R, Pieczek A, Halez L et al. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation, 1997; 95: 1988-2002. (Pubitemid 27184264)
17. Komatsu R, Ueda M, Naruko T et al. Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. Circulation, 1998; 98: 224-233. (Pubitemid 28337613)
18. Hoffmann R, Monts GS, Dussaillant GR et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation, 1996; 94: 1247-1254.
19. Heller LI, Shemwell KC, Hug K et al. Late stent thrombosis in the absence of prior intracoronary brachytherapy. Cather Cardiovasc Intervent, 2001; 53: 23-28. (Pubitemid 32405742)
20. Wang F, Stouffer GA, Waxman S et al. Late coronary stent thrombosis: Early vs. late stent thrombosis in the stent era. Cathet Cardiovasc Intervent, 2002; 55: 142-147. (Pubitemid 34127369)
21. Walters DL, Harding SA, Walsh CR et al. Acute coronary syndrome is a common clinical presentation of in-stent restenosis. Am J Cardiol, 2002; 89: 491-494.
22. Shoming A, Neumann FJ, Kastrati A et al. A randomised comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med, 1996; 334: 1084-1089.
23. Leon MB, Baim DS, Popma JJ et al. A clinical trial comparing three antithrombotic-drug regiment after coronary-artery stent ing. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med, 1998; 339: 1665-1671.
24. Mak KH, Belli G, Ellis SG et al. Subacute stent thrombosis: evolving issues and current concepts. J Am Coll Cardiol, 1996; 27: 494-503.
25. Moreno PR, Palacios IF, Leon MN et al. Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue. Am J Cardiol, 1999; 84: 462-466.
26. Fineschi M, Carrera A, Gori T. Atheromatous degeneration of the neointima in a bare metal stent: intravascular ultrasound evidence. J Cardiovasc Med, 2009; 10: 572-572.
27. Ueda Y, Nanto S, Komamura K et al. Neointimal coverage of stents in human coronary arteries observed by angioscopy. J Am Coll Cardiol, 1994; 23: 341-346.
28. Assali AR, Moustapha A, Sdringola S et al. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (The PRESTO Trial). Am J Cardiol, 2006; 98: 729-733.
29. Chen MS, John JM, Chew DP et al. Bare metal stent restenosis is not a benign clinical entity. Am Heart J, 2006; 151: 1260-1264.
30. Nayak AK, Kawamura A, Nesto RW et al. Myocardial infarction as a presentation of clinical in-stent restenosis. Circ J, 2006; 70: 1026-1029. (Pubitemid 44161740)
31. Steinberg DH, Pinto Slottow TL, Buch AN et al. Impact of instent restenosis on death and myocardial infarction. Am J Cardiol, 2007; 100: 1109-1113.
32. Bainey KR, Norris CM, Graham MM et al. Clinical in-stent restenosis with bare metal stents: is it truly a benign phenomenon? Intern J Cardiol, 2008; 128: 378-382.
33. De Labriolle A, Bonello L, Lemesle G et al. Clinical presentation and outcome of patients hospitalised for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents. Arch Cardiovasc Dis, 2009; 102: 209-217.
34. Bonello L, De Labriolle A, Lemesle G et al. Comparison of outcomes of drug-eluting stents versus bare metal stents in nonostial proximal left anterior descending coronary arteries. Am J Cardiol, 2009; 103: 496-500.